Biostatisticians developed a new tool to address one of the big problems slowing progress toward universal access to antiretroviral therapy for AIDS in developing nations. It helps to prioritize laboratory-based CD-4 cell count testing and allocate resources to the patients who need them the most.
Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of researchers have now demonstrated that these cells can actually attack HIV-infected cells in a living organism.
Anal cancer is on the rise among HIV-positive women, according to a Montefiore Medical Center study entitled, “High Prevalence of High Grade Anal Intraepithelial Neoplasia in HIV-Infected Women Screened for Anal Cancer,” to be published in the Journal of Aids on May 1.
Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus compared to women who’ve only been infected once. These findings, by researchers at Fred Hutchinson Cancer Research Center in Seattle, are published online March 29 in PLoS Pathogens.
New research from the University of Adelaide shows why the development of a cure and new treatments for HIV have been so difficult for scientists to crack.
In a four-year study, funded by the Centers for Disease Control and Prevention's Minority AIDS Research Initiative, researchers will conduct and evaluate an HIV/AIDS anti-stigma related intervention among 10 African-American congregations in rural Alabama. The overall goal of the project, “Faith-Based Anti-Stigma Intervention Toward Healing HIV/AIDS,” or Project FAITHH, is to decrease both individual and community-wide stigma in these congregations.
Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV) found in late-stage AIDS.
Research done by Australian scientist Jack da Silva, PhD, and published in the March issue of the journal GENETICS, suggests that even in early infection, when the virus population is low and has reduced genetic variation, HIV rapidly evolves to evade immune defenses and treatment.
Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women. Scientists have known for years that traumatized women are at greater risk of becoming infected.
A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, according to a study by researchers at RTI International.
A national team of AIDS experts at Johns Hopkins and elsewhere say they are surprised and dismayed by results of their new study showing that the yearly number of new cases of HIV infection among black women in Baltimore and other cities is five times higher than previously thought. The data show that infection rates for HIV, the virus that causes AIDS, among this population are much higher than the overall incidence rates in the United States for African-American adolescents and African-American women.
This is the first to demonstrate that the biological mechanism that keeps the HIV virus hidden and unreachable by current antiviral therapies can be targeted and interrupted in humans, providing new hope for a strategy to eradicate HIV completely.
Using human immune system cells in the lab, AIDS experts at Johns Hopkins have figured out a way to kill off latent forms of HIV that hide in infected T cells long after antiretroviral therapy has successfully stalled viral replication to undetectable levels in blood tests.
A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, reports a study in the March issue of AIDS. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The International Association of Physicians in AIDS Care (IAPAC) publishes new set of evidence-based guidelines to overcome common barriers to optimal care for patients of all ages
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.
Leading AIDS experts at Johns Hopkins and other institutions around the world have issued new guidelines to promote entry into and retention in HIV care, as well as adherence to HIV treatment, drawn from the results of 325 studies conducted with tens of thousands of people infected with HIV, the virus that causes AIDS.
A drug once taken by people with HIV/AIDS but long ago shelved after newer, modern antiretroviral therapies became available has now shed light on how the human body uses its natural immunity to fight the virus—work that could help uncover new targets for drugs.
Scientists have identified a promising strategy for vaccine design using a mathematical technique that has also been used in analyses of stock market price fluctuations. The team will give an update on its work at the Biophysical Society 56th Annual Meeting in San Diego, Calif.
Problems with correct condom use, such as not wearing a condom throughout sex or putting it on upside down, are common in the U.S. and have become a major concern of public health officials. Countries around the world are facing similar challenges.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right